Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 06  •  04:00PM ET
32.95
Dollar change
+0.82
Percentage change
2.54
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsU.S. Return% 1Y3.59% Total Holdings51 Perf Week-1.43%
SponsorThemes ETFs ETF Type Tagsequity Return% 3Y- AUM964.05K Perf Month-3.10%
Fund Family Bond Type Tagsmid-large-cap Return% 5Y- NAV/sh Perf Quarter-3.43%
IndexSolactive US R&D Champions Index Average Maturity TagsR&D Return% 10Y 52W High35.18 -6.33% Perf Half Y-1.98%
Index Weighting Commodity Type Tags- Return% SI 52W Low23.68 39.16% Perf YTD-1.00%
Active/Passive Quant Type Tags- Flows% 1M0.00% Volatility0.10% 0.07% Perf Year8.14%
Dividend TTM0.14 (0.42%) ESG Type Tags- Flows% 3M0.00% ATR (14)0.33 Perf 3Y-
Dividend Ex-DateDec 18, 2025 Dividend Type Sector/Theme Flows% YTD0.00% RSI (14)44.28 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta1.28 Perf 10Y-
Expense0.29% Growth/Value SMA20-1.65% Flows% 3Y Rel Volume1.92 Prev Close32.14
Inverse/Leveraged Market Cap SMA50-1.92% Flows% 5Y Avg Volume0.05K Price32.95
IPODec 13, 2023 Option/ShortYes / No SMA2003.34% Trades Volume99 Change2.54%
Themes US R&D Champions ETF seeks to track the performance, before fees and expenses, of the Solactive US R&D Champions Index. The index is designed to provide exposure to U.S. companies in the large- and mid- capitalization segments that rank in the top 50 companies based on the index Provider's R&D intensity metric. The fund will invest, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in securities that comprise the index. The fund is non-diversified.